ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $154,000 | -48.1% | 62,873 | 0.0% | 0.00% | – |
| Q4 2019 | $297,000 | +40.1% | 62,873 | +26.7% | 0.00% | – |
| Q3 2019 | $212,000 | +42.3% | 49,619 | +147.1% | 0.00% | – |
| Q1 2016 | $149,000 | -77.8% | 20,079 | -75.1% | 0.00% | -100.0% |
| Q4 2015 | $671,000 | -32.2% | 80,793 | -26.5% | 0.00% | -50.0% |
| Q3 2015 | $990,000 | -40.5% | 109,926 | -20.8% | 0.00% | -33.3% |
| Q2 2015 | $1,665,000 | +160.2% | 138,758 | +133.6% | 0.00% | +200.0% |
| Q1 2015 | $640,000 | +91.0% | 59,400 | -53.2% | 0.00% | 0.0% |
| Q3 2014 | $335,000 | -33.4% | 127,000 | +1.7% | 0.00% | 0.0% |
| Q2 2014 | $503,000 | +305.6% | 124,900 | +362.6% | 0.00% | – |
| Q1 2014 | $124,000 | +5.1% | 27,000 | -1.1% | 0.00% | – |
| Q4 2013 | $118,000 | +9.3% | 27,300 | 0.0% | 0.00% | – |
| Q3 2013 | $108,000 | +89.5% | 27,300 | 0.0% | 0.00% | – |
| Q2 2013 | $57,000 | -50.0% | 27,300 | 0.0% | 0.00% | – |
| Q4 2012 | $114,000 | – | 27,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 12,546,493 | $22,835,000 | 1.71% |
| MSD Partners, L.P. | 15,151,516 | $27,576,000 | 0.84% |
| MSD Partners, L.P. | 7,575,758 | $13,788,000 | 0.42% |
| CHIRON CAPITAL MANAGEMENT, LLC | 198,002 | $360,000 | 0.26% |
| Avidity Partners Management LP | 3,000,000 | $5,460,000 | 0.12% |
| Old West Investment Management, LLC | 211,513 | $384,000 | 0.10% |
| MAGNOLIA CAPITAL ADVISORS LLC | 103,239 | $188,000 | 0.07% |
| Virtus ETF Advisers LLC | 72,060 | $131,000 | 0.06% |
| ACT WEALTH MANAGEMENT, LLC | 34,454 | $91,000 | 0.06% |
| Allred Capital Management, LLC | 53,000 | $96,000 | 0.05% |